Professor Annie Koh is Professor Emeritus of Finance (Practice) at Lee Kong Chian School of Business, Singapore Management University (SMU). She is a renowned conference speaker, panel moderator and commentator. She chairs the Asian Bond Fund 2 supervisory committee for the Monetary Authority of Singapore and is a committee member of Singapore’s Customs Advisory Council. She has recently been appointed board member of Singapore Food Agency with effect from April 1st 2023.

Professor Koh is currently Chairman of Prime US REIT and an independent director of AMTD IDEA Group, Prudential Assurance Company Singapore Pte Ltd, Yoma Strategic Holdings Ltd and EtonHouse Community Fund (Charity), She previously served on GovTech, Singapore’s CPF, HMI, K1 Ventures boards, and was a member of the World Economic Forum Global Future Council from 2019 – 2022, and the HR Industry Transformation Advisory Panel from 2018 – March 2023.

Professor Koh also advises selected single-family offices and privately owned enterprises such as Flexxon Pte Ltd., PBA Group and TOP International, and startups such as Dedoco, Float Foods Pte Ltd, Hyperscal Solutions Pte Ltd, Pyxis Maritime Pte Ltd, and non-profits such as Blockchain Association of Singapore and Cyber Youth Singapore. She has been an investment committee member of iGlobe Partners since July 2010, advisor to CUBE3 Ventures since October 2021, and Asia Food Sustainability Fund since February 2022.. She has been an investment committee member of iGlobe Partners since July 2010, advisor to CUBE3 Ventures since October 2021, and Asia Food Sustainability Fund since February 2022. Previously held leadership positions at SMU include Vice President for Business Development; V3 Group Professor of Family Entrepreneurship; Academic Director of Business Families Institute and International Trading Institute; Associate Dean, Lee Kong Chian School of Business; and Dean, Office of Executive and Professional Education.

Professor Koh received her Ph.D. degree in International Finance as a Fulbright scholar from Stern School of Business, New York University in 1988. Her research interests are in Family Office and Family Business, Investor Behaviour, Alternative Investments and Enterprise Risk Management. She co-authored Financial Management: Theory and Practice, 2nd edition (2021), and Financing Internationalisation – Growth Strategies for Successful Companies (2004), co-editor of Asian Family Business: Succession, Governance and Innovation (2020), and author of a number of Asian family business cases and survey reports. In recognition of her contribution to education and the public sector, she was awarded the bronze and silver Singapore Public Administration medal in 2010 and 2016 respectively, and the Adult Education Prism Award in 2017.

Ho 教授是新加坡国立大学医学教授；国立大学医院高级顾问；国立大学卫生系统医疗保健创新中心主任。除了是一位卓有成就的内窥镜医师之外，他还是一位国际关键意见领袖，被印度胃肠内窥镜学会授予终身荣誉会员，并被授予日本胃肠内窥镜学会院士，以表彰他对胃肠内窥镜领域的重大贡献。

他在领导亚洲研究人员之间的合作方面拥有丰富的经验，是亚洲 EUS 小组的主席。他还是亚洲肠道与肥胖（“Go Asia”）工作组的联合主席，以及美国 NIH-NCS 发起的Asian Barrett’s Consortium。

作为一位久经考验的临床医生创新者和经验丰富的企业家，他共同发明了主从穿腔内窥镜机器人 (MASTER)，该机器人后来被分拆为初创公司 Endomaster。Endomaster 成为 2017 年亚洲最佳融资医疗科技初创企业。他还创立了另外两家初创公司：Endofotonics（一种基于分子人工智能的实时诊断系统）和 Endopil（一种可摄入的减肥气球胶囊）。 2012年，他荣获新加坡总统技术奖。

他是新加坡国立大学医学院前任副院长。他还曾担任新加坡国立大学医学系主任。 2005年，他担任新加坡胃肠病学会主席。为了表彰他对医学界的杰出贡献，新加坡卫生部授予他著名的杰出高级临床医生奖。他于 2017 年被授予公共行政（铜）奖章。他拥有 6 项美国授予的医疗技术产品专利。

Since founding Catcha Group in 1999, Patrick has built an extensive track record of founding, building, acquiring, listing and growing both private and public Southeast Asian digital businesses. Today, he is widely recognized as one of the leading entrepreneurs in the region, having founded and taken 5 digital businesses from their early stages to initial public offering in Australia and Southeast Asia, including the iProperty Group – which was acquired by REA Group in 2016 in one of the largest ever acquisitions of a Southeast Asian internet company at the time; iCar Asia, an operator of leading automobile marketplaces in Southeast Asia; and Frontier Digital Ventures, an owner and operator of leading online marketplaces in frontier markets. 

Patrick is passionate about leveraging Catcha’s entrepreneurial and capital markets expertise to help great tech entrepreneurs scale and take their companies to the public markets. 
  
He has been independently and widely recognised by a number of international awards, including: Global Leader of Tomorrow by the World Economic Forum; New Asian Leader by the World Economic Forum; Young Entrepreneur of the Year by the Australian Chamber of Commerce, Singapore; Asia’s Best Young Entrepreneur by Bloomberg Business; and the University of Sydney’s 2021 Alumni Award for International Achievement.

As Chief Impact Officer, Sugandhi leads the firm’s approach towards assessing, measuring, consolidating and driving impact outcomes across its portfolio companies, in order to deliver measurable, positive impact alongside compelling financial returns. She also leads investments in South and South-Asia for the firm.

Sugandhi has over 18 years of investing experience in South and Southeast Asia. She was previously Director of Investments at LeapFrog Investments, a billion-dollar impact fund focused on financial inclusion. Prior to impact investing, she focused on Southeast Asia mid-market private equity at emerging markets investor Actis. Sugandhi began her investing journey as a member of the Financial Services team in Temasek Holdings.

An experienced board member, Sugandhi has held board directorships in companies operating across different countries, including India, Thailand, and Indonesia. She currently sits on the board of Cropin, a global artificial intelligence and data-led agri-tech organization based in India; HealthCare At Home, an out-of-hospital care provider in India; Polymateria, a UK based business that has pioneered biotransformation technology for plastic and the enterprise board of the Institute of Innovation & Entrepreneurship at the Singapore Management University.

Sugandhi is an advocate of gender equality and actively commits time to mentor women entrepreneurs as well as women-led ventures. She believes that access to education, employment, and entrepreneurship is the key to elevating lives and livelihoods.

Sugandhi holds a Master of Business Administration from the Indian Institute of Management, Bangalore (India), and a Bachelor of Engineering from Maharaja Sayaji Rao University, Baroda (India).

雅国博士目前是新加坡理工学院 (SIT) 的工程学教授，同时也是该学院院长的顾问。

在担任现职之前，雅国博士曾担任新加坡通讯及新闻部（2011 年至 2018 年）、环境自然资源及水务署（2004 年至 2011 年）以及社区发展和体育部（2002 年至 2004 年）的部长。

在担任部长的16年里，他还担任主管穆斯林事务的部长。他于 1997 年 1 月 2 日作为惹兰勿刹集选区国会议员开始了他的政治生涯。在 2002 年成为部长之前，他曾担任过多项政治任命。

雅国博士 1980 年毕业于新加坡大学土木工程专业，1980 年至 1984 年在一家跨国工程咨询公司担任结构工程师。1984 年在斯坦福大学攻读博士学位，1989 年毕业。此后，他在康奈尔大学做了两年博士后。 1990 年，他作为教员加入新加坡国立大学，并成为终身会员。他从 1998 年 7 月起在新加坡国立大学休学，直至 2018 年 8 月从新加坡国立大学辞职。

他目前是建筑和木材工业雇员工会 (BATU) 董事会成员以及盛裕国际 (Surbana-Jurong International) 董事会成员。他是多家初创企业的顾问，并担任运输初创企业 MobilityX 的顾问小组主席。

他还是资讯通信媒体发展局(IMDA) 甘榜格南数字化项目的顾问。 他目前是惹兰勿刹集选区国会议员。

高先生负责推动集团的数字化进程，专注于在集团各业务领域打造并扩大关键的数字化能力。他也是集团的碳管理业务GoNetZero™的平台创始人。

高先生在能源、金融、酒店、物流和咨询等行业拥有25年的数字化业务经验，在淡马锡控股、麦肯锡、百事可乐等公司担任过各种高级职位。加入胜科前，高先生在亚洲领先的金融服务集团星展银行领导Future Ready和Future of Work平台。他也负责该银行的5G、区块链和物联网在跨行业生态系统中的应用，以及通过对话式人工智能达成数字化方案实现。他也创办了一家科技初创公司，并带领公司实现盈利。

高先生持有伦敦经济学院经济学与管理学学士学位。

拥有超过 35 年的半导体供应链管理经验，并在 IDM 和外包业务领域拥有丰富的经验。

为IC设计中心、客户服务、FAE等各职能部门的设置提供强有力的管理支持获得从 IC 前端到后端运营和 CM 的广泛制造知识。

良好的 IC 产品知识，涵盖数字、模拟到混合信号设备。 与所有业务合作伙伴、机构和工作团队发展并建立良好的支持和工作关系。

Jan Lim 是亚马逊新加坡电子商务市场业务的国家主管兼总经理。 Jan 的团队涵盖销售和客户管理、卖家招聘和营销、战略合作伙伴关系、区域扩张、产品和项目开发、履行和运营等端到端业务。

Jan 目前担任亚马逊新加坡董事会成员、新加坡企业发展局服务标准委员会成员，并被新加坡资讯通讯及媒体发展管理局授予 2023 年新加坡数字领袖奖。 Jan 是亚马逊亚太地区 Bar Raiser 核心领导者，负责引进人才 Bar Raiser（抬杠者）和亚太地区学生项目执行委员会成员，为 MBA 和毕业生招聘制定方向。作为亚马逊地区的 Bar Raiser 及人员和团队领导者，Jan 确保了强大的创新文化和以客户为中心的文化，并增加了他在亚马逊识别、招聘和培养此类人才和领导者方面的经验。

Jan 毕业于伦敦大学学院，获得统计、计算机、运筹学和经济学学士学位，之前的工作经验涉及 Visa、Deloitte、Credit Suisse 和 EssenceMediacom 等全球组织的创业、数字营销、咨询和支付。

Robert is a Singaporean business leader involved in Renewable Energy, Built Environment & Sustainability, Technology and Private Equity. He is Chairman of Swan & Maclaren Group, one of Singapore’s prominent architectural, design and illumination engineering firm that contributed to Singapore’s historical landmarks for the past 125 years. Swan & Maclaren Group has presence in 10 international markets including Europe and the Middle-East.

Concurrently, Robert is Advisory Board Chairman of EDPR APAC, a member of EDPR Group listed on Euronext, Dow Jones Sustainability and Bloomberg Gender-Equality Index. EDPR Group is the 4th largest producer of renewable energy worldwide with presence in over 28 international markets. 

Robert is an Independent Director with EDPR APAC, NTUC FairPrice Group, Jurong Port, IMDA Singapore and Alexandra Health Fund Limited. In February 2022, he was appointed by the Monetary Authority of Singapore (MAS) as member of the Corporate Governance Advisory Committee. In January 2023, he was appointed as Chairman of Sustainability for NTUC FairPrice Group.
 
Robert held a distinguished career before retiring in December of 2014. He joined DFS Group (a member of LVMH Group of Companies) global leadership in 2004 and was the Executive Vice President. During the same period, he was President, DFS Venture Singapore and a member of LVMH global CIO council. Prior to joining DFS, Robert was CEO, East Asia at PSA International.

Between 2006 till 2014, Robert was a member of IBM Corporation, Global Advisory Board in New York. His past board directorships of SGX listed companies included supply chain and technology companies. During 2014 till 2018, Robert represented Singapore as a council member for the ASEAN Business Advisory Council and Deputy Secretary for Singapore National Employers Federation.

In January 2020, Robert was conferred Singapore Management University (SMU) Distinguished Fellow and the inaugural Dean’s Fellow with the School of Computing and Information Systems for his contribution as eminent leader in the industry. 

Robert was conferred a Bachelor degree in Mechanical Engineering with honours in 1987 and Masters of Engineering Science in 1989 from UNSW in Sydney.

Kheng Nam Lee 作为风险投资者和技术高管拥有丰富的经验。

他于 2005 年作为风险合伙人加入纪源资本，并在 Heptagon 被 AMS 成功收购后担任董事长。 Kheng Nam 也是 Advantec Pte Ltd 的主席、Vertex Management (II) Pte Ltd 的主席和 Vertex Venture Holdings Ltd (VVH) 的副主席，这两家公司都是淡马锡控股（私人）有限公司的全资子公司。

Rob 是 Seraphim Space Manager LLP 的普通合伙人，该公司是全球领先的 SpaceTech 专业投资者，也是伦敦证券交易所上市公司 Seraphim Space Investment Trust Plc 的经理，负责早期投资。他是 Seraphim Space Accelerator 的联合创始人，该加速器于 2018 年推出，现已成为全球领先的 SpaceTech 初创企业加速器项目之一。在 Rob 的指导下，Seraphim Space Accelerator 已使 81 家 SpaceTech 初创企业成功毕业，这些初创企业已从 90 多家风险资本投资者的联合投资中总共筹集了 3 亿美元。他是 Xona Space Systems、Altitude Angel 和其他早期投资公司董事会的基金代表。 Rob 拥有格拉斯哥大学生物医学科学（荣誉）理学士学位和斯特拉斯克莱德大学信息技术系统研究生文凭 (PGDip)。

Sebastian Chong 先生是伟仕佳杰（新加坡）私人有限公司的总裁，该公司是在香港联交所上市（0856.HK）的伟仕佳佳控股有限公司的新加坡子公司。 Chong先生还兼任伟仕佳杰印度尼西亚子公司PT ECS Indo Jaya的总裁。庄先生于1990年加入伟仕佳杰，在IT行业拥有超过30年的经验。他负责战略方向和整体管理，包括伟仕杰新加坡和印度尼西亚的企业、商业、消费者和零售部门的销售和运营。 Chong 先生还负责业务开发、业务战略以及与供应商、渠道和合作伙伴建立长期关系。

Semun 于 2018 年 4 月加入新加坡时装协会，在她的领导下，该协会获得了 2019 年运营 Design Orchard 联合办公空间和 2020 年零售空间的任命，并启动了 The Bridge Fashion Innovator (TBFI) 孵化计划2019 年，该组织以时尚行业为目标。2022 年中，该组织进行了品牌转型，从纺织时尚联合会 (TaFF) 转型为新加坡时装理事会 (SFC)，以体现其服务整个时尚价值链的更广泛目标。

在加入 SFC 之前，她曾在 SGTech（前身为新加坡信息通信技术联合会）工作，并担任该组织的执行董事 11 年。在此之前，她曾担任新泽西州普林斯顿人力资源咨询公司 Caliper（新加坡办事处）的总经理。

她还曾在摩托罗拉电子工作了 10 年，负责东南亚移动设备业务的业务运营、战略规划和产品营销。 Semun 随后被任命为区域总监，负责东南亚配件业务，她的业务呈指数级增长。

Semun 目前是设计教育咨询委员会 (DEAC)、ITE 设计和媒体学术咨询委员会 (AAC) 以及淡马锡理工学院设计咨询委员会的成员，以进一步加强学校与行业之间的联系。她是 2021 年 Made With Passion (MWP) 战略委员会的成员，以提高当地设计师的意识，并且是零售服务技术委员会的成员。

Albert is currently the CEO, Biobot Surgical Pte Ltd a robotic company focus in prostate management. He is step-changing Biobot commercial capabilities so that Biobot can better impact patients’ health and delight our customers across the globe. He will lead our talented global team to position Biobot’s leading robotic technology to be best-in-class for prostate disease management.   
 
Albert has extensive global healthcare experience and a proven track record in managing diverse markets,  go-to-market strategies and innovative pipeline development. He has spent 26 years in the healthcare industry with the largest healthcare MNCs like Johnson & Johnson and Danaher’s Beckman Coulter in roles of increasing responsibility including sales, marketing, commercial excellence, general management, and product development across different business units, such as Danaher’s Beckman Coulter, Janssen Pharmaceutical, DePuy Synthes, Ethicon and Johnson & Johnson Medical, and geographies including the U.S., U.K, EMEA. and Asia. 

In his last role with Johnson & Johnson, Albert was Vice President Global Commercial Leader, Gastroenterology, Immunology for Janssen Pharmaceutical Companies, based in Pennsylvania, USA. He was instrumental in building an industry-leading pipeline and portfolio in close partnership with R&D leaders. Furthermore, he led a global launch of a mega block-buster brand, Stelara, to transform the standard-of-care in gastroenterology and achieve peak year sales of US$7 billion in 2021. Prior to that, he was the Managing Director for Johnson & Johnson Singapore where he transformed the go-to-market model and achieved high compound annual growth rate (CAGR). Before that, Albert was General Manager, ASEAN for DePuy Synthes and in this role he successfully integrated two orthopedic organizations across six countries, formulated and executed strategic plans for the region and achieved double-digit growth. 

Albert is also an active community member. He was elected Chairman of Medical Technology Industry Group from 2014-2018 in Singapore. He was also on the Board of Directors of the Singapore Association of Pharmaceuticals Industries (SAPI) and the Alumni Advisory Board of Nanyang Technological University Business School from 2015-2020. 

Albert holds a Bachelor of Business, in Marketing from Nanyang Technological University in Singapore and MBA from Duke University. Albert and his family currently reside in Singapore.

Anselm Tan 是 Heritas Capital 的董事总经理，该公司投资于医疗保健、教育、环境和技术领域。他目前担任Singapore Deep Tech Alliance的顾问委员以及医疗保健创新资助评估小组成员。

此前，Anselm 是 Philips Ventures 的合伙人，他在该公司发起并领导了亚太地区的健康技术投资。Anselm 的职业生涯始于工程，之后在渣打银行 (Standard Chartered) 担任金融和私募股权职务。

Anselm 是新加坡人，是一名合格的会计专业人士，拥有南洋理工大学电气与电子工程学位。他在斯坦福大学接受了专业教育，并在上海交通大学接受了中国文化教育。

临床副教授 Goh Bee Tin 是新加坡国家牙科中心首席执行官、SingHealth Duke NUS 口腔健康学术临床项目（Oral Health Academic Clinical Programme）主席以及新加坡国家牙科研究所（National Dental Research Institute Singapore）创始主任。

Cl A/Goh 教授于 1993 年从新加坡国立大学 (NUS) 获得牙科外科学士学位。随后，她继续专攻口腔颌面外科领域，并于 1996 年获得爱丁堡皇家外科医学院牙科奖学金，1997 年获得新加坡国立大学牙科硕士学位。2000年，她被录取为新加坡医学院院士。同年，她获得政府奖学金，在加拿大接受唇裂、腭裂和正颌手术的高级培训。

2004年，她在瑞典和英国继续接受颅面移植学培训。 2009 年，她凭借在下颌骨重建模块化内置假体方面的新颖研究工作，获得了荷兰奈梅亨内梅亨大学的博士学位。 Cl A/Goh 教授还被任命为新加坡国立大学牙科学院和杜克新加坡国立大学医学院的临床副教授，以及南洋理工大学的兼职副教授。

她积极从事研究生的教学和培训工作。她的研究兴趣包括骨再生生物工程、口腔颌面器械开发以及下颌重建新技术。 Cl A/Goh 教授是新加坡牙科理事会（Singapore Dental Council ）和牙科专家认证委员会的成员。她因其在临床组织工程方面的工作而获得了 Osteopore 创新奖，因其学术成就而获得了 SingHealth GCEO 杰出临床医生研究员奖和杜克大学新加坡国立大学硕士学术临床医生奖，并因其对公共医疗保健的贡献而获得了国庆奖和公共行政（铜）奖章。

Chew Men Leong 是新科工程城市解决方案部总裁，该集团是一家全球技术、国防和工程集团，业务涵盖航空航天、智慧城市、国防和公共安全领域。他于 2021 年 1 月 1 日上任，领导集团在移动、公用事业和基础设施、安全和可持续解决方案领域的全球智慧城市业务。

Men Leong 此前曾担任该集团的首席营销官，负责监督智慧城市解决方案和国防出口的营销，同时兼任其海洋部门的副总裁和总裁（国防业务）。

在加入新科工程之前，Men Leong 在政府部门担任过各种高级管理和领导职务。他曾担任陆路交通管理局首席执行官，负责监督新加坡交通系统的运营和改造。他还担任公用事业局委员会首席执行官，负责确保新加坡充足且可持续的供水。

Men Leong 的职业生涯始于新加坡武装部队 (SAF)，服役 25 年。在此期间，他担任过多项职务，包括担任新加坡海军 (RSN) 司令。

Men Leong 毕业于伦敦帝国理工学院，获得电气与电子工程学士学位（一级荣誉）。他拥有斯坦福大学管理学硕士学位，并完成了沃顿商学院的高级管理课程。

David Tan 先生是裕廊集团 (JTC) 的助理首席执行官（发展集团）。裕廊集团是新加坡负责规划和开发工业基础设施，以支持和促进新产业增长并改造现有企业的主要政府机构。他负责监督土地规划和重建、建筑、采购和合同管理，以及裕廊集团下一代产业的规划和开发，如 one-north、裕廊创新区、榜鹅数字区和兀兰北海岸。

David Tan 先生拥有工程和行业开发方面的专业经验；参与重大基础设施、建筑和填海项目的规划、设计和施工。他参与了世界十大化学和能源中心裕廊岛以及东南亚第一个地下液态碳氢化合物储存和终端设施裕廊岩洞的开发。 2007年至2010年，他担任新加坡能源市场管理局副首席执行官，参与能源政策、规划和发展。

目前，David Tan 先生担任 Jurong Port Pte Ltd 和 SLI Holdings Pte Ltd 的董事会成员。他也是新加坡财政部发展项目咨询小组和 MOH Holdings Pte Ltd 的医疗基础设施和规划委员会以及项目开发委员会的成员。

David Tan 先生毕业于阿德莱德大学土木工程（一级荣誉）学士学位和新加坡国立大学工程硕士学位。 2005年，他被授予公共行政（铜）奖章，2014年，他被授予公共行政（银）奖章，以表彰他对公共服务的贡献。

Dr. Daniel Fung 是一位儿童和青少年精神病学家，也是新加坡心理卫生学院的首席执行官。他是新加坡所有 3 所医学院的兼职副教授。

Dr. Daniel Fung 是国际儿童青少年精神医学及相关学科协会 (IACAPAP) 主席（2018-2022 年）以及新加坡医学院精神科医生学院院长。Dr. Daniel Fung 与人合着了 200 多篇经过同行评审的研究论文、书籍和书籍章节。Dr. Daniel Fung 一直积极参与新加坡远程精神病学的发展，并在过去 10 年中开发了许多数字心理健康解决方案，包括针对多动症的专利新型治疗方法。

Steven graduated from National University of Singapore in 1992 and went on to pursue his interest in Humanitarian and Disaster medicine with the Singapore Armed Forces from 1992 to 2002. Upon completion of his dermatology training in Singapore, Steven went on to Amsterdam Medical Centre, Netherlands, to continue his training in pigmentary disorder, under Professor Westerhof. Upon returning from his training, Dr Steven Thng started the pigment clinic in National Skin Centre as well as set up the melanocyte culture lab to start his work on cultured melanocytes grafting for vitiligo patients. 

Currently, Dr Thng is the head of the pigment clinic, in charge of managing all complex pigmentary disorders in National Skin Centre, and he is also the principal surgeon for tissue grafting for vitiligo.  

Steven took over as Executive Director of Skin Research Institute of Singapore in Jan 2017, and is responsible for the transformation of SRIS from a virtual institute to a dynamic institute, working on 4 main multi-institutional, interdisciplinary research programs of chronic wound, acne, skin microbiome and atopic dermatitis.  

His current research interest is on skin pigmentary disorder, atopic dermatitis, novel drug delivery systems, as well as advanced imaging for skin cancer and skin diseases. He has translated much of his research to improve patient care in dermatology.  

For his dedication in research and patient care, he was awarded Excellence in Public Service Award in 2013, Healthcare Humanity Award in 2014, Singapore Clinician Investigator Award in 2015 and 2016. Steven was also awarded NMRC CSA in Feb 2020 to further his work on in-vivo imaging systems.

A/Prof Tan’s experience spans from acute to community-based hospital care and primary care. His passion lies in the integration of care across the diverse settings that patients will traverse during their care journey. His leadership and academic appointments include Chief Executive Officer and Senior Consultant Physician of St Luke’s Hospital; 
Chairman, Chapter of Family Medicine, Academy of Medicine Singapore and Adjunct Associate Professor at both National University of Singapore and Yong Loo Lin School of Medicine & Duke-NUS Medical School.
 
A/Prof Tan was conferred with the following awards during his span in healthcare services:
• MOH National Outstanding Clinician Educator Award 2019 under the National Medical Excellence Awards (NMEA) 
• CFPS ‘The Albert & Mary Lim’s Award’ 2019 (the highest accolade bestowed by the CFPS for contribution and services rendered to the College and the discipline of Family Medicine).
• AIC Super Committed Hero Award 2021 [(served most number of years in the same committee (2010-2020)] and Supertasking Hero Award [(served most number of years accumulatively in various committees (2010-2020)] for journeying with AIC in driving the development and capability building in the community care sector. 
• CFPS “Distinguished Educators Award” on 14 May 2022 (in recognition of leadership contributions to teaching family medicine and dedicated service of at least 10 years in College’s education activities)

Timothy Low 博士目前担任花拉公园医院董事会成员，也是 Pavilion Capital（淡马锡控股公司）的医疗保健投资主管。

在此之前，Timothy Low 博士曾担任花拉公园医院 (Farrer Park Hospital) 的首席执行官，该医院是一家私立急性高等教育机构，位于新加坡第一个完全一体化的医疗保健和酒店综合体内。分别荣获2016/2017年度“亚太区最佳新医院”和“亚太区年度智慧医院”奖。

Timothy Low 博士在公共和私人诊所拥有 30 多年的从业经验，他将自己的操作和医学知识运用到了这一职位上。他曾担任鹰阁医院首席执行官，以及夏尔/武田、柯惠医疗/美敦力、先灵葆雅/默沙东、科文斯和葛兰素威康生物制药、医疗器械和 CRO 行业的医疗事务高级主管，时间跨度超过 17 年。

Timothy Low 博士于 2018 年荣获“医疗保健杰出人物 - 年度领先医疗保健管理专业人士”称号，并于 2016 年和 2017 年分别荣获“亚洲 50 名最具才华的医疗保健领袖”奖以及“年度最佳首席执行官”奖。 2018年，他被授予“亚太地区年度罕见病冠军提供者”称号，随后又被评为2019年“最具媒体洞察力人物”。

Elaine Heng 女士担任 FairPrice Group (FPG) 零售业务首席执行官兼集团副首席执行官。 FPG 包括 NTUC FairPrice、NTUC Foodfare、Kopitiam 和 NTUC Link。作为 FPG 集团副首席执行官，Elaine 支持集团首席执行官，推动整个集团的关键战略举措，以利用和协同不同的业务部门和职能。目前，FPG 拥有近 570 个消费者接触点，拥有超过 14,000 名员工，年营业额超过 45 亿元。作为零售业务首席执行官，她负责监督合作社零售业务的整体业务、战略、管理和成就，其中包括十个品牌的 FairPrice 超市、大卖场、电子商务平台、药店和便利店。她采用以客户为中心、卓越运营和数据驱动的绩效来重新思考零售业，在转变 FairPrice 的业务模式并确保其在行业中的领先地位方面发挥了重要作用。

在她的领导下，她引入了新的相关零售概念，在 Vivocity、Parkway Parade 和其他一些中心地带商店的 FairPrice Xtra 门店融合了售卖熟食和食品杂货。她还推出了在疫情期间向社区提供食品杂货的 FairPrice on Wheels，以及迎合不同客户群体的 Freshmart 和 Finest Gourmet。 Fairprice 还推出了无人值守的 Cheers 便利店，利用人工智能为顾客提供更多便利。

此外，Elaine 代表 FPG 和 NTUC Enterprise 领导了这一里程碑式项目，将数字银行（信托银行）纳入该集团的产品组合中。目前，该信托基金在推出后 9 个月内就为超过 10% 的新加坡人口提供了银行服务。在 2017 年加入 FairPrice 集团之前，Elaine 是一名拥有 20 多年的零售银行和财富管理经验的银行家。

对于过去几年对行业的贡献，Elaine 被 Retail Asia 评为 2023 年度（亚太地区）首席执行官。

Dr Guan Seng Khoo has over 28 years’ of experience in the design and implementation of enterprise wide investment, banking and risk management models, systems and processes incl. ESG/Responsible Investing. He gained deep practical insights from a career spanning across financial institutions in the USA, Canada, UK and Singapore, including the UK-listed Man Group where he was the Principal Scientist, designing and running an algorithmic AI-based hedge fund, at American Bourses Corporation which provided robo-based analytical solutions and financial info-utilities to traders and investors in the USA and N Asia, at ATOS Origin, RHB Capital, Singapore Exchange, Standard Chartered Bank, Temasek Holdings, Alberta Investment Management Corporation (AIMCo), CAI, the global airport investment arm of Changi Airport Group (CAG) and AEPW (Alliance to End Plastic Waste). He holds a PhD in Computational Physics (Material Science) from the National University of Singapore, with post-doc R&D in AI-based data mining and applications in Japan and America. He was also a co-founder of the NTU Centre for Financial Engineering and the MSc in Financial Engineering programme in collaboration with Carnegie Mellon University, Pittsburgh in 1999. 

ESG & Sustainable Finance Experience 

When he was the Head of ERM/GRC at AIMCo, he was also the Head of Proxy Voting and a member of the investment committee involved in approving investments via Relationship Investing/Stakeholder Engagement, e.g., in ERM (Environmental Resources Management) and Glass-Lewis, and also, helping to establish the Responsible Investing (RI) Unit in 2011. For the last few years, he has also been leading some initiatives in sustainability-related project and impact financing and education incl. sustainability reporting at AEPW and at sustainable investing seminars for the institutional & investment management and banking industry, at SMU, private and wholesale banks in the ASEAN region and the SWF Academy at the London Business School (Dubai and London campuses) including on harnessing AI in investing. 

Previously, when he was an academic at NTU from 1993 to 2000, together with his Science Faculty colleagues, he co-designed and launched the first Environmental Science module (as a free elective for all the NTU undergrads) in 1997, including teaching on the effects of climate change on human society and biodiversity. Prior to that, he had published a Nature Guide on the Flora and Fauna of Schools in Singapore in 1991 and also participated in a Malayan Nature Society Scientific Expedition to the Endau-Rompin Nature Reserve in Malaysia in 1989 to investigate and research on the changing state of biodiversity due to climate change and human interactions. As an academic, he had also published over 70 papers in renowned academic journals and conference proceedings on materials science, education, banking, investment and risk management topics. 

黄女士是国家公园管理局的首席执行官。她在公共服务领域拥有 20 多年的经验，包括在市区重建局担任新加坡首席规划师，并曾在新加坡总理公署和新加坡国家发展部战略小组任职。她是陆路交通管理局、科学馆董事会、滨海湾花园和 IJ 管理委员会的董事会成员。她目前担任新加坡-ETH 中心未来城市实验室全球研究计划的科学咨询委员会和城市土地学会亚太执行委员会的成员。

Ivan Ng 是城市发展有限公司的首席技术官，该公司是一家在 29 个国家开展业务的全球房地产领导者。他负责集团 IT、数字化举措和技术风险治理。

Ivan 拥有 25 年领导业务和技术团队的经验，对技术的创新使用创造商业价值带来了独特的见解。他曾担任 ServiceNow 的区域董事总经理（他在该公司建立了大中华区和东南亚业务），以及纳斯达克上市 IT 服务公司文思海辉技术有限公司 (Pactera) 的首席技术官。 Ivan 目前居住在新加坡，在中国、美国、日本、印度尼西亚和泰国居住和工作了超过 15 年。

Ivan 目前担任 IT Management Association（新加坡）主席，并在多家科技公司的董事会任职。他是新加坡国立大学、新加坡滨海湾花园和淡马锡理工学院的顾问。 2018年，他被新加坡国立大学授予杰出校友奖。

Prof Damian O’Connell is Chief Executive Officer the Experimental Drug Development Centre, a national platform for drug and biomarker discovery as well as early clinical development, hosted by A*STAR. 

Most recently Damian was Senior Vice President, Drug Discovery – Global Head of Clinical Sciences, Bayer Pharma AG, Berlin – Germany. Clinical Sciences (CS) is a global organization (based Germany, US, Japan, China) with responsibility for the first use of drug products in humans up to Proof of Concept, as well as all clinical pharmacological components of NDAs.

Prof O’Connell previously held senior positions within Pfizer Research & Development, Parke Davis, Elan Pharmaceuticals and Neurex. Prof O’Connell has both MD & PhD degrees from the National University of Ireland, has been a Medical Faculty member of the University of Virginia Health Sciences Center as well as a member of the Clinical Pharmacology & Therapeutics Department at the University College Cork, Ireland where he was a Professor of Clinical Research. He started his career in the Industry in 1998. 

Prof O’Connell is a Member of the Faculty of Pharmaceutical Medicine; Fellow of The Royal Society of Medicine; Fellow of The Royal Academy of Medicine (Ireland); Member of the British Pharmacological Society; Member of the Drug Safety Executive Council (DSEC); Member American Society for Clinical Pharmacology and Therapeutics; Member American College of Clinical Pharmacology; Member of American Society of Pharmacometrics; Member of the Irish Association of Pharmacologists; Member of the Irish Cardiac Society; and Member of the British Hypertension Society.

NG graduated in 1977 with BSc – Civil Engineering from Queen Mary College, London University, MSc - Water Resources Engineering – 1978, and PhD (dissertation on chemical regeneration of activated carbon) in 1980 from Birmingham University.  NG subsequently conducted post-doctoral research on biotreatment systems at Kyoto University, Japan. He is a fellow at the Institute of Engineers, a chartered engineer, and is a registered professional engineer with the Professional Engineers Board, Singapore.

NG had served as Dean, Faculty of Engineering at the National University of Singapore and this was ranked 9th globally in 2004 by THE. He had served as Dean, College of Engineering at Nanyang Technological University (till 2015) and the College was then globally ranked 5th by US News in 2014 and 2015, and 9th by QS in 2014, and 6th in 2015. During his tenure as Dean, the College of Engineering saw a reversal in declining student interest in engineering and improvement in terms of freshman undergraduate student quality, expansion of industry sponsored research, and formation of joint research laboratories with multi-national companies in domains such as aerospace, manufacturing, and electronics. 

NG had been seconded in 2006 to the then Ministry of the Environment to initiate development of its R&D and funding programme.  Thereafter he founded and led as its Executive Director for 10 years, the Nanyang Environment & Water Research Institute (NEWRI), before retiring from the position in 2017 and after having brought in cumulative funding of some S$570M. NEWRI had operated as an ecosystem of units covering research, technology development and de-risking, postgraduate education, interface with industry and community, and a cluster of spin-off companies. It carried facilities from laboratory to demo/full-scale (eg. membrane, anaerobic digestion and gasification/vitrification facilities), allowing pursuit of the Research-Engineering-Enterprise-Deployment (REED) value chain espoused by NG and hence had close industry interactions by way of R&D collaborations and technology commercialization while maintaining research depth and excellence.  NEWRI also, unusually, carried its own philanthropic unit with projects at numerous locations in Asia (eg. Indoensia, India and Sri Lanka) providing safe water and sanitation. It had operated with some 360 researchers and support staff. In 2013 NEWRI and NG were identified among the top 9 global environmental engineering research organizations and among the top 25 global environmental engineering thought leaders respectively by LUX Research.  Arising from his R&D management and leadership roles, NG had also served as advisor to research entities in other countries such as the Waterloo Water Institute, Canada. 

NG’s contributions to industry, research, and education have been recognized with the ASEAN Engineering Award, Outstanding University Researcher Award, and the Chevalier dans l’Ordre des Palmes Academiques prior to 2000.  His project on the anaerobic process for low strength wastewater was placed first in the national innovation competition for environmental technologies in 2004, and in 2008 he was appointed the inaugural Tan Chin Tuan Centennial Chair Professor. In 2012 he was honored with election to Fellow Singapore Academy of Engineering.  In 2017 his work was recognised with the IES Prestigious Engineering Award, Singapore Energy Award, ASEAN Engineering Excellence Award, and the President’s Technology Award.  In 2018 he was recognised as among the top 100 scientists in Asia and with the Nanyang Award for Humanitarian Work, and in 2019 was appointed a President’s Chair Professor in Civil & Environmental Engineering at NTU.  In 2020 he was appointed Distinguished Professor at Universiti Kebangsaan Malaysia.  Following retirement from his academic career, he was conferred the Emeritus Professor title at NTU in 2022. 

杨副教授 1997 年毕业于新加坡国立大学，并获得医学和外科学士学位。随后，他在美国接受培训，并获得了美国内科医学委员会的内科、心血管科和介入心脏病学认证。目前，杨副教授是新加坡国家心脏中心 (NHCS) 的高级介入心脏病专家顾问。他还是 NHCS 首席执行官 (CEO) 以及 SingHealth 杜克-新加坡国立大学心血管医学 ACP 学术主席。杨教授还担任新加坡保健集团副首席医疗信息官（研究）。

杨副教授是新加坡心脏病学会理事会成员。他还是美国心脏协会、欧洲心脏病学会 (FESC)、美国心脏病学会 (FACC)、亚太心脏病学会 (FAPSC)、亚太介入心脏病学会和美国心脏病学会 (FAPSC) 的会员。心血管血管造影和干预（FSCAI）。他是亚太心脏病学会科学顾问委员会主席。他在国际同行评审期刊上发表了大量文章，并且是《Circulation》、《美国心脏病学杂志》、《Heart》、《美国心脏病学会杂志：心血管干预》、《韩国循环杂志》、《结构心脏》、《亚洲干预》、《东盟心脏杂志》的同行评审员、医学科学院年鉴和新加坡医学杂志。他是《Korea Circulation Journal》和《AsiaIntervention》的编辑委员会成员。他被亚太心脏病学会任命为其《APSC 杂志》的创始主编。他是新加坡医学院心脏病学家分会的前任主席，也是亚太心脏病学会科学顾问委员会的主席。他是新加坡医学院内科医师学院的董事会成员。

杨副教授对使用经皮或导管技术治疗二尖瓣和三尖瓣特别感兴趣。他曾在区域和国际会议上多次就 MitraClip 设备的亚洲经验发表演讲，并建立了 MARS 注册中心（MitraClip 亚太注册中心）。在他的另一个主要研究兴趣中，杨副教授对健康服务研究中的长期心血管结果以及利用数据科学来深入了解心脏病的诊断和管理感兴趣。他发表了多篇论文，比较大型研究的结果，包括来自美国大型注册中心的研究结果。他是 SingCLOUD 登记处的 PI，该登记处是所有冠状动脉疾病和心力衰竭患者的国家登记处。 SingCLOUD 注册中心将包括所有重组后的医院和综合诊所；它将在新加坡跟踪这些患者 1-3 年的临床、成本和护理质量结果。杨博士也是新加坡一项前瞻性观察性研究或普通志愿者 SingHEART 的 PI。 SingHEART 将全基因组测序与深度表型分析（心脏 MRI、CT 钙评分、动态血压和心电图、健身追踪器和血液测试）以及 20 年的长期临床随访相结合。

ROBYN DITTRICH is a passionate, high-energy industry professional, with over 30 years’ experience in the Chemical, Mining, Manufacturing, Technology, Financial Services and Oil & Gas sectors. 

Her current role as VP, Global Operations Programs at BHP, oversees and drives delivery of initiatives across multiple teams to eliminate sexual assault & harassment, racism and bullying at BHP, and supports the work of the COO office and BHP board committees. 

Prior to this, she has held VP roles in Procurement, and Analysis & Improvement at BHP and various Sales VP roles for S&P Global, BP, Canon, and Hercules Chemicals, and front-line operational roles at Visy Industries.

Expertise areas include P&L management, business strategy and transformation, CEO & board engagement, driving business growth strategies, commercial innovation, enabling digital transformation, supply chain decarbonisation, organizational capability development, strategic eco-system partnerships, and creating social value. 

ROBYN DITTRICH holds a Bachelor of Chemical Engineering (Honours) degree from Monash University, and an MBA from Edinburgh Business School (Heriot-Watt University). 

External engagements and memberships. 
A strong advocate of workplace culture, Robyn is an active contributor to several programs which support,  mentor and provide leadership skills to diverse employees across Asia. Robyn has led several LGBT and Women’s employee networks in several multi-national organisations, partnering with multiple stakeholders to provide measurable, business driven outcomes for diverse talent. She is a passionate about STEM (Science, Technology, Engineering, and Mathematics) and speaks across several forums to inspire young people to take up STEM-based careers.

Tan Bin Ru is a renowned leader in the Fintech industry globally and a prominent figure in the Singapore blockchain community. As the Chairwoman of the Blockchain Association of Singapore (BAS), she leads the organization with the vision to be the leading industry organization for the advocacy, collaboration, convergence, and fair use of blockchain and scalable technologies in Singapore. 

Bin Ru is a regular speaker at various Fintech events on Artificial Intelligence & Blockchain including Singapore Fintech Festival, Singapore Blockchain Fest, Abu Dhabi Finance Week, Singapore – India Hackathon 2023 (Fintech & ESG) and many more. Through her speaking engagements, Bin Ru aims to promote the adoption and responsible use of blockchain technology in various industries and sectors. 

Currently, Bin Ru serves as President, Enterprise Digital in Singapore Technologies Engineering in addition to her role as the Chairwoman of the BAS,. With over 25 years of experience , Bin Ru has lead several leadership roles in MNCs and startups, Notable roles includes Deputy CEO and COO of ChainUp Pte Ltd, a leading blockchain technology solutions provider for digital asset exchanges and institutions and CEO (Southeast Asia) of OneConnect Financial Technology Co. Ltd., a technology-as-a-service platform for financial institutions. Bin Ru also held various leadership roles at Microsoft and Hewlett Packard. 

Bin Ru's contributions to the Singapore fintech industry have been recognized with numerous accolades, including being named "Top 5 Women in FinTech" and "Asia FinTech Leaders" at the 2019 Singapore FinTech Awards. Bin Ru was also recognized with the "Woman in Fintech" award by Fintech Nation 65 in 2022. She is also a role model for women in the tech sector and was featured in the inaugural Singapore 100 Women in Tech List in 2020. 

Bin Ru holds a Bachelor’s Degree in Mathematics from National University of Singapore. She is also a certified Six Sigma Master Black Belt.  

Yen brings years of Asia and technology knowledge, vast experience in corporate governance and gender 
diversity to board discussions. In over ten years, she has held non-executive independent roles on public and 
private organisations in Singapore and Europe. She is currently Director OCBC Bank , Jardine Cycle & Carriage 
Ltd, ams-OSRAM AG# and Barry Callebaut AG# (listed in SIX Swiss Exchange), and non listed boards InCorp Global 
Pte Ltd and EdgeConneX Inc.

Past Non-Executive roles include:

• Gemalto NV (Euronext Paris and NL)
• Singapore Institute of Directors
• Defence Science & Technology of Singapore
• Cap Vista Pte. Ltd
• Singapore Press Holdings

Yen Yen Tan is a veteran in the technology and telecommunications sectors. She has over three decades of experience in driving strategy and operational execution in multinational companies.

• Vodafone Global Enterprise – President, Asia Pacific
• SAS Institute – Regional Vice President and Managing Director of Asia Pacific (South)
• Oracle – Senior Vice President of Applications, APAC
• Hewlett-Packard – Vice President and Managing Director, Singapore

Yen is currently working part time as Senior Advisor to 2 Private Equity firms, TA Associates, a Boston Private Equity firm focus on growth stage companies and Infrasturure fund team in EQT Partners, a Swedish Private Equity firm.

Her other part time advisory work includes being a consultant in SC Ventures Brain Trust, a venture review forum in creating new business models for the Standard Chartered Bank’s fintech startups. She is also Senior Advisors to global IT Consulting firm’s CEO of Capgemini Asia Pacific and Middle East.

Yen believes in giving back to the community, hence she volunteers in positions that resonate with her cause in STEM education, technology and sports excellence. As the Chairman of Singapore Science Centre, she has been involved in shaping the Centre for further development and in strengthening the Centre’s relationships with various stakeholders and partners. She is also in the Executive Committee of International Women’s Forum (IWF), a global forum for most accomplished women in the world.

Yen Yen plays a pivotal role in Singapore's infocomm industry. Her influence in the technology sector comes not just from her ability to grow markets, but also from her ability as a people-builder. She mentors early stage startups through her startup fund she founded in TNF Ventures. Her past contributions include:

• Chairman of the Singapore Infocomm Technology Federation
• Infocomm Development Authority (IDA) of Singapore
• Corporate Capabilities and Innovation sub committee with the Singapore Government Future Economy
• National University of Singapore, School of Computing, Advisory board members

In 2020, she was elected in the inaugural “SG 100 Women in Tech” list, an initiative by Infocomm Media Development Authority and Singapore Computer Society to recognise women who have impressed, inspired and made significant contributions to tech industry in Singapore.

Her passion in sports have helped her build high-performance teams at work. She currently chairs the High Performance Sports SpexBusiness Network Advisory Board for Sports SG. And was a member of ASEAN Para  Games Organising Steering Committee.

For her contribution and distinguished services to Singapore, the President of Republic of Singapore appointed her as Justice of the Peace in 2018. She was also awarded The Public Service PBM (Pingat Bakti Masyarakat) Medal in 2020, in recognition for her commendable public service in Singapore and her achievement in her profession.

Yen Yen is an award-winning corporate leader; she has earned a reputation for her years of contribution to the technology industry.

• Top 10 women in The Peak’s 2015 Power List
• Outstanding Alumni award by NUS School of Computing (2014)
• ‘IT Leader Award 2011’ by the Singapore Computer Society (SCS)
• 7th International Management Action Award (IMAA) in 2010
• ‘Most inspiring Women’ by Women’s Weekly 2009 Great Women of our Time Awards

Yen Yen has an Executive MBA degree with Helsinki School of Economics Executive Education and a degree in 
Computer Science from National University of Singapore

冯廷辉是现任吉宝集团数据中心与网络部门首席执行官。该部门是新加坡领先的主板上市公司吉宝企业有限公司连接平台的一部分。吉宝是一家全球资产管理公司，在互联互通、基础设施和房地产领域拥有深厚的运营能力。目前管理着500亿新元的资产。

冯廷辉于2002年加入吉宝的岸外与海事业务担任高级经理（并购整合部门）。他在2007年升任为总经理（企业发展），负责该业务的投资、兼并与收购和战略规划。2010年6月至2014年6月期间，他担任吉宝基础设施信托的信托机构管理公司——吉宝基础设施基金管理私人有限公司首席执行官。

在此之前，冯廷辉于1998年至2001年期间担任祥峰投资管理（英国）的投资经理，在1995年至1998年期间担任新加坡旅游局副总裁（中美区），并在1988年至1995年期间担任新加坡经济发展局的助理主管（企业发展部服务组）。新加坡旅游局和新加坡经济发展局都是新加坡贸工部下属的经济机构。

Xiaowei 是世界能源理事会亚洲特别项目主任，负责提高理事会知名度和该地区的商业机会。Xiaowei也是美国智库世界大型企业联合会的战略传播委员会的亚洲项目总监 。

在此之前，Xiaowei 已在壳牌工作超过 26 年，曾在中国、英国、荷兰和新加坡担任各种职务，最近担任亚太地区对外关系区域副总裁，任期至 2021 年 7 月。 Xiaowei 在利益相关者参与、可持续发展、宣传、社会 绩效、风险/问题/危机管理和媒体关系，并领导了赢得全球奖项和认可的项目和活动 。

目前，Xiaowei 是新加坡营销协会和Advisory Board of GGEF（一家促进可持续发展的社会企业）的董事会成员。自 2023 年起，她是在新加坡大学和学院的可持续发展和战略传播讲师。Xiaowei 是经过认证的 Gallup StrengthFinder 教练和已发表的 《My Public Affairs Career》一书的作者。

Xiaowei 拥有北京外国语大学艺术与社会科学学士学位和伦敦政治经济学院政治经济学硕士学位 。她中英文流利，在新加坡生活和工作。

黄榆镔先生于2014年创立云启资本。 黄榆镔先生自 2000年进入风险投资行业以来，已有 20 年时间，专注于智能网联、机器人、人工智能、大数据等领域的早中期投资机会。他在智能网联创业及供应链管理方面具备丰富的经验。 创立云启资本前，黄榆镔先生曾长期任职于 GGV纪源资本（以下简称 GGV），2004 年至 2008 年期间，他常驻 GGV 美国硅谷办公室，帮助 GGV 在美国的智能硬件投资业务发展；2008 年 至 2014 年期间，他常驻 GGV 上海办公室。2014 年，他和毛丞宇先生共同创立了云启资本。 2000年至2004年间，黄榆镔先生还曾就职于GIC 新加坡政府投资公司。加入GIC前，他还曾工作于Sun Microsystem。 黄榆镔先生拥有斯坦福大学硕士学位和新加坡南洋商学院 MBA 学位和拥有美国旧金山大学学士学位。 2017，2018年，2019年黄榆镔先生连续获得了福布斯 “中国最佳创业投资人” 称号，并于2018年进入了前30名。

Dr Ramesh is a fellowship trained orthopaedic surgeon who specializes in Shoulder and Knee Surgery. After his residency training in Singapore at Tan Tock Seng Hospital, he completed a Shoulder and Knee Surgery fellowship at the Santry Sports Surgery Clinic in Dublin, Ireland. He also went on to do a further sports surgery fellowship with Hospital Quiron and Hospital Del Mar in Barcelona, Spain. As part of his fellowship stints, he was involved in treating international professional rugby players and soccer players.

He now practises at the Avant Sports, Shoulder and Elbow Surgery, which is part of the Avant Orthopaedics group of clinics. He is available for consultation at his clinics with the Parkway Group of Hospitals –Mount Elizabeth Novena and Parkway East Hospital. He is also a visiting consultant with Tan Tock Seng Hospital and Ng Teng Fong General Hospital.

He consults for general orthopaedic problems, but his main area of expertise is in the area of shoulder and knee surgery. He also has a special interest in treating sports injuries and is one of few surgeons in Singapore who are trained in hip arthroscopy.

Dr Ramesh has a strong commitment to teaching and mentorship. He had been appointed Adjunct Assistant Professor in Orthopaedics for Yong Loo Lin School of Medicine (National University of Singapore). He has also served as clinical teacher for Lee Kong Chian School of Medicine. He has previously served as Chairman of the Hand Surgery Residency Program in Tan Tock Seng Hospital and is also involved in teaching Orthopaedic Surgery Residents and post-graduates. He has been fellowship program supervisor for clinical fellows from Malaysia, Phillipines and India. He has also been a lecturer and clinical faculty for local and overseas arthroscopic workshops and courses.

Pauline 担任国家健康创新中心主任，负责促进公立医院集团临床创新的开发和商业化。在此之前，她负责总理办公室国家研究基金会的创新与企业理事会，制定了新加坡科技生态系统的关键标志，例如新加坡创新与技术周 (SWITCH)、早期风险基金和其他国际和公私伙伴关系。 Pauline 还曾在业界担任过新加坡工商联合会技术、创新和生产力主席、瑞银集团执行董事兼创新合作主管以及 Celligenics 首席运营官/首席战略官

Wong Wai Meng 先生现任数据中心及网络部首席执行官（数据中心）。他在信息和通信技术 (ICT) 行业拥有近 30 年的经验，目前带领公司努力成为欧洲和亚太地区领先的数据中心开发商和解决方案提供商之一。在加入吉宝讯通之前，Wong Wai Meng 先生曾担任 BT Advise BT Global Services 亚太地区、中东、非洲和土耳其 (AMEA) 地区的副总裁，负责管理公司在业务咨询、系统集成、软件开发、网络、移动、协作和安全。他还是 BT Frontline 集团公司的首席执行官，在 BT Frontline 与 BT Global Services 的整合过程中发挥了关键作用。Wong Wai Meng先生现担任SGTech执行委员会主席、新加坡工商联合会理事会成员和数字化委员会主席，并活跃于多个行业小组和委员会。

Wong Wai Meng 先生现任数据中心及网络部首席执行官（数据中心）。他在信息和通信技术 (ICT) 行业拥有近 30 年的经验，目前带领公司努力成为欧洲和亚太地区领先的数据中心开发商和解决方案提供商之一。在加入吉宝讯通之前，Wong Wai Meng 先生曾担任 BT Advise BT Global Services 亚太地区、中东、非洲和土耳其 (AMEA) 地区的副总裁，负责管理公司在业务咨询、系统集成、软件开发、网络、移动、协作和安全。他还是 BT Frontline 集团公司的首席执行官，在 BT Frontline 与 BT Global Services 的整合过程中发挥了关键作用。Wong Wai Meng先生现担任SGTech执行委员会主席、新加坡工商联合会理事会成员和数字化委员会主席，并活跃于多个行业小组和委员会。

Wong Wai Meng 先生现任数据中心及网络部首席执行官（数据中心）。他在信息和通信技术 (ICT) 行业拥有近 30 年的经验，目前带领公司努力成为欧洲和亚太地区领先的数据中心开发商和解决方案提供商之一。在加入吉宝讯通之前，Wong Wai Meng 先生曾担任 BT Advise BT Global Services 亚太地区、中东、非洲和土耳其 (AMEA) 地区的副总裁，负责管理公司在业务咨询、系统集成、软件开发、网络、移动、协作和安全。他还是 BT Frontline 集团公司的首席执行官，在 BT Frontline 与 BT Global Services 的整合过程中发挥了关键作用。Wong Wai Meng先生现担任SGTech执行委员会主席、新加坡工商联合会理事会成员和数字化委员会主席，并活跃于多个行业小组和委员会。

Wong Wai Meng 先生现任数据中心及网络部首席执行官（数据中心）。他在信息和通信技术 (ICT) 行业拥有近 30 年的经验，目前带领公司努力成为欧洲和亚太地区领先的数据中心开发商和解决方案提供商之一。在加入吉宝讯通之前，Wong Wai Meng 先生曾担任 BT Advise BT Global Services 亚太地区、中东、非洲和土耳其 (AMEA) 地区的副总裁，负责管理公司在业务咨询、系统集成、软件开发、网络、移动、协作和安全。他还是 BT Frontline 集团公司的首席执行官，在 BT Frontline 与 BT Global Services 的整合过程中发挥了关键作用。Wong Wai Meng先生现担任SGTech执行委员会主席、新加坡工商联合会理事会成员和数字化委员会主席，并活跃于多个行业小组和委员会。

Wong Wai Meng 先生现任数据中心及网络部首席执行官（数据中心）。他在信息和通信技术 (ICT) 行业拥有近 30 年的经验，目前带领公司努力成为欧洲和亚太地区领先的数据中心开发商和解决方案提供商之一。在加入吉宝讯通之前，Wong Wai Meng 先生曾担任 BT Advise BT Global Services 亚太地区、中东、非洲和土耳其 (AMEA) 地区的副总裁，负责管理公司在业务咨询、系统集成、软件开发、网络、移动、协作和安全。他还是 BT Frontline 集团公司的首席执行官，在 BT Frontline 与 BT Global Services 的整合过程中发挥了关键作用。Wong Wai Meng先生现担任SGTech执行委员会主席、新加坡工商联合会理事会成员和数字化委员会主席，并活跃于多个行业小组和委员会。